GPT and Hyperbilirubinemia: Laboratory work-up demonstrated reduction of transaminases (AST 170 IU/L, ALT 248 IU/L), worsening of hyperbilirubinemia (total bilirubin 15.2 mg/dl), stable coagulopathy (INR 2.3), mild hyperferritinemia (327 ng/ml) and increase in white blood cell count (21.5/mm3) with neutrophils 86.7% and absence of ANA, ASMA, AMA, anti-LKM, anti-dsDNA, and ANCA serum antibodies (Table 1).